SCLX
Scilex Holding CompanyNASDAQ
Healthcare • Drug Manufacturers - General
Updated 1 day ago
Coverage limited
$2.88+2.86%
Close Oct 13, 2026
- Market cap
- $19.85M
- 1 month
- -43.5%
- 3 months
- -68.8%
- 1 year
- -69.0%
- Dividend
- No dividends on record
- Short interest
- 3.0% of float171.2K shares · settled Sep 30, 2026 · -3.1% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $31.61M
- Net income
- -$447.12M
- Free cash flow
- -$17.46M
- Book value
- —
- Total debt
- $95.56M
- P/E
- —
- Price / sales
- —
- Price / book
- —
- FCF yield
- —
- Net margin
- -1,414.6%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if SCLX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
9 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
71 filers reported a long position in SCLX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Share changes are not shown: the share count changed through a corporate action (2026-06-16 803:500 adjustment, 2026-06-16 1606:1000 adjustment).
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.4M | 301.3K | — |
| BlackRock, Inc. | $853.5K | 109.4K | — |
| VANGUARD FIDUCIARY TRUST CO | $357.4K | 45.8K | — |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $321.1K | 41.2K | — |
| STATE STREET CORP | $275.9K | 35.4K | — |
| UBS Group AG | $260.3K | 33.4K | — |
| RENAISSANCE TECHNOLOGIES LLC | $257.9K | 33.1K | — |
| CITADEL ADVISORS LLC | $214.5K | 27.5K | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | $164K | 20.9K | — |
| Ashton Thomas Private Wealth, LLC | $144.2K | 18.5K | — |
Get the Full Analysis for SCLX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.